In the research context the molecule also appears in combination protocols for tendons and joints together with BPC-157 and TB-500
Liposomal encapsulation provides up to 16 times greater bioavailability than standard oral glutathione supplements
Between these older two, semaglutide appears most effective with an average of 10%15% of body weight loss over a year, followed by liraglutide with ~5%10% of body weight lost
GLP-1 Drug Market Drivers Innovations in Drug Delivery Systems Advancements in drug delivery systems are poised to enhance the efficacy and patient compliance of GLP-1 therapies
Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Deschenes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P (2012) A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety